NO20004722L - Faste, hurtigdesintegrerende cetirizin-formuleringer - Google Patents

Faste, hurtigdesintegrerende cetirizin-formuleringer

Info

Publication number
NO20004722L
NO20004722L NO20004722A NO20004722A NO20004722L NO 20004722 L NO20004722 L NO 20004722L NO 20004722 A NO20004722 A NO 20004722A NO 20004722 A NO20004722 A NO 20004722A NO 20004722 L NO20004722 L NO 20004722L
Authority
NO
Norway
Prior art keywords
disintegrating
fast
solid
cetirizine formulations
cetirizine
Prior art date
Application number
NO20004722A
Other languages
English (en)
Other versions
NO20004722D0 (no
NO329071B1 (no
Inventor
Wolfram Tritthart
Mario Andre Piskernig
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO20004722D0 publication Critical patent/NO20004722D0/no
Publication of NO20004722L publication Critical patent/NO20004722L/no
Publication of NO329071B1 publication Critical patent/NO329071B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20004722A 1998-03-31 2000-09-21 Faste, hurtig desintegrerende cetirizin-formuleringer NO329071B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814256A DE19814256A1 (de) 1998-03-31 1998-03-31 Feste, schnellzerfallende Cetirizin-Formulierungen
PCT/DE1999/000799 WO1999049843A1 (de) 1998-03-31 1999-03-20 Feste, schnellzerfallende cetirizin-formulierungen

Publications (3)

Publication Number Publication Date
NO20004722D0 NO20004722D0 (no) 2000-09-21
NO20004722L true NO20004722L (no) 2000-09-21
NO329071B1 NO329071B1 (no) 2010-08-16

Family

ID=7863014

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004722A NO329071B1 (no) 1998-03-31 2000-09-21 Faste, hurtig desintegrerende cetirizin-formuleringer

Country Status (30)

Country Link
US (1) US6245353B1 (no)
EP (1) EP1067904B1 (no)
JP (1) JP2002509873A (no)
KR (1) KR100653568B1 (no)
CN (1) CN1136838C (no)
AR (1) AR018828A1 (no)
AT (1) ATE209899T1 (no)
AU (1) AU750140B2 (no)
BG (1) BG64741B1 (no)
BR (1) BR9909233A (no)
CA (1) CA2326809C (no)
CY (1) CY1107331T1 (no)
CZ (1) CZ300704B6 (no)
DE (2) DE19814256A1 (no)
DK (1) DK1067904T3 (no)
ES (1) ES2168013T3 (no)
HU (1) HU227477B1 (no)
IL (1) IL138606A (no)
NO (1) NO329071B1 (no)
NZ (1) NZ506988A (no)
PL (1) PL191266B1 (no)
PT (1) PT1067904E (no)
RU (1) RU2216318C2 (no)
SI (1) SI1067904T1 (no)
SK (1) SK284476B6 (no)
TR (1) TR200002809T2 (no)
TW (1) TWI233808B (no)
UA (1) UA57615C2 (no)
WO (1) WO1999049843A1 (no)
ZA (1) ZA200005134B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100863146B1 (ko) 2000-07-17 2008-10-14 아스텔라스세이야쿠 가부시키가이샤 경구 흡수 개선 의약 조성물
CN101632642B (zh) * 2002-01-15 2011-06-08 Ucb法奇姆股份有限公司 口感和稳定性改善的配方
CN100335041C (zh) * 2002-04-04 2007-09-05 辉瑞产品公司 美味咀嚼片剂
WO2005115345A1 (en) * 2004-05-28 2005-12-08 Imaginot Pty Ltd Oral therapeutic compound delivery system
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
EP2522365B1 (en) 2004-11-24 2016-10-26 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
EP3263117A1 (en) 2005-11-28 2018-01-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
EP2344137B1 (en) * 2008-09-05 2015-12-02 Johnson & Johnson Consumer Inc. Method for making cetirizine tablets
MX357919B (es) * 2009-03-13 2018-07-25 Nucitec Sa De Cv Composición farmacéutica para el tratamiento de la hipercolesterolemia.
WO2011146032A2 (en) * 2010-05-18 2011-11-24 Mahmut Bilgic Effervescent formulations
WO2013188483A1 (en) 2012-06-12 2013-12-19 The Procter & Gamble Company Effervescent dosage form
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
TWI732337B (zh) * 2014-06-20 2021-07-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
JP2018108950A (ja) * 2016-12-28 2018-07-12 沢井製薬株式会社 レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (en) * 2017-11-15 2019-05-23 Berkeley Nox Limited Novel dietary supplements
PT3799864T (pt) 2019-10-02 2023-05-25 Intas Pharmaceuticals Ltd Composições farmacêuticas sólidas efervescentes essencialmente isentas de sódio
AU2021217209A1 (en) * 2020-02-03 2022-09-29 Kenvue Brands Llc A single layer chewable tablet comprising cetirizine
CN120437087A (zh) 2024-02-01 2025-08-08 科赴品牌有限责任公司 一种口腔溶解膜制剂、其用途及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
US5876752A (en) * 1990-08-07 1999-03-02 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
SK279279B6 (sk) * 1991-05-13 1998-09-09 The Boots Company Plc S(-)-nátrium-2-(4-izobutylfenyl)propionát-dihydrát
GB9119052D0 (en) * 1991-09-06 1991-10-23 Boots Co Plc Pharmaceutical compositions
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
NZ256346A (en) * 1992-10-09 1997-04-24 Procter & Gamble Medicaments containing 3-l-menthoxypropane-1,2-diol for treating cold symptoms
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
ES2091654T3 (es) * 1993-04-15 1996-11-01 Gergely Gerhard Sistema efervescente que contiene un ingrediente activo farmaceutico sensible a alcalis y/o metales, y procedimiento para su produccion.
FI955144A7 (fi) * 1993-04-30 1995-10-31 Procter & Gamble Päällystetyt farmaseuttiset koostumukset
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
IL138606A (en) 2005-07-25
CZ20003481A3 (en) 2001-05-16
AU750140B2 (en) 2002-07-11
NO20004722D0 (no) 2000-09-21
PL343199A1 (en) 2001-07-30
JP2002509873A (ja) 2002-04-02
BG104843A (en) 2001-07-31
RU2216318C2 (ru) 2003-11-20
NO329071B1 (no) 2010-08-16
UA57615C2 (uk) 2003-06-16
NZ506988A (en) 2002-05-31
KR20010034718A (ko) 2001-04-25
EP1067904B1 (de) 2001-12-05
TR200002809T2 (tr) 2000-12-21
HUP0102676A3 (en) 2002-12-28
ZA200005134B (en) 2000-12-21
AU3925399A (en) 1999-10-18
EP1067904A1 (de) 2001-01-17
DE19814256A1 (de) 1999-10-07
SI1067904T1 (en) 2002-04-30
TWI233808B (en) 2005-06-11
SK284476B6 (sk) 2005-04-01
PT1067904E (pt) 2002-05-31
CZ300704B6 (cs) 2009-07-22
CY1107331T1 (el) 2012-12-19
SK14312000A3 (sk) 2001-07-10
HUP0102676A2 (hu) 2001-11-28
ES2168013T3 (es) 2002-05-16
KR100653568B1 (ko) 2006-12-05
IL138606A0 (en) 2001-10-31
CN1136838C (zh) 2004-02-04
AR018828A1 (es) 2001-12-12
CN1295464A (zh) 2001-05-16
BR9909233A (pt) 2000-11-28
BG64741B1 (bg) 2006-02-28
ATE209899T1 (de) 2001-12-15
CA2326809C (en) 2008-11-18
WO1999049843A1 (de) 1999-10-07
HK1036217A1 (en) 2001-12-28
DE59900501D1 (de) 2002-01-17
DK1067904T3 (da) 2002-04-02
US6245353B1 (en) 2001-06-12
PL191266B1 (pl) 2006-04-28
CA2326809A1 (en) 1999-10-07
HU227477B1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
NO20004722D0 (no) Faste, hurtigdesintegrerende cetirizin-formuleringer
TR199901077A3 (tr) Ispençiyari formülasyonlar.
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
NO20004240D0 (no) Formuleringer
ATE224703T1 (de) Brauseformulierungen
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
DE69826127D1 (de) 2-substituierte 4,5-diarylimidazole
PT1130966E (pt) Formulacoes antiparasitarias
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
ID29635A (id) Formulasi mikrokapsul
IS6398A (is) Lyfjablöndur
PT1210349E (pt) Pirazolo-¬4,3-d|-pirimidinas
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
ID27655A (id) Formulasi mikrokapsul
NO20003825L (no) 1,3,4 - oxadiazolonderivater
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
ATE234839T1 (de) 4,5-azolo-oxindole
DE60014639D1 (de) Riechstoffe
DE69908356D1 (de) Riechstoffe
AR027974A1 (es) 1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas
ES1042496Y (es) "pilona sumible".
ITRM20000199A0 (it) Formulazione.
ES1039752Y (es) Almohada perfeccionada.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees